192 web-developer-university-of-liverpool Postdoctoral research jobs at University of Oxford
Sort by
Refine Your Search
-
learning and computational methods. In addition, candidates should provide evidence of creative and critical thinking as applied to the development and execution of a cohesive programme of research. A
-
Department of Medicine. The translational immunotherapy lab, led by Professor Melero, focuses on the development, study, and mechanistic understanding of innovative immunotherapeutic strategies for cancer
-
The University of Oxford is a stimulating work environment, which enjoys an international reputation as a world-class centre of excellence. Our research plays a key role in tackling many global
-
The University of Oxford is a stimulating work environment, which enjoys an international reputation as a world-class centre of excellence. Our research plays a key role in tackling many global
-
research papers should not be provided at this stage. The closing date for applications is 12.00 midday 5th September 2025, UK time. Interviews will be held as soon as possible thereafter. The University
-
learning, at the intersection of reinforcement learning, deep learning and computer vision, in order to train effective robotic agents in simulation. You should hold a relevant PhD/DPhil (or near completion
-
advanced functional genomics, transcriptomics, and proteomics approaches, you will develop novel therapeutic strategies for cancer immunotherapy. You will be responsible for managing your own academic
-
Research Council and led by the University of Exeter (you will report to Professor Kate Saunders in Oxford). The post is based in the Department of Psychiatry at the Warneford Hospital Oxford. The post is
-
, attack surfaces, defensive mechanisms and related topics to the safe deployment of systems contain multiple LLM and VLM powered models. You will be responsible for Developing and implementing; capability
-
relevant assays to interrogate dysregulation induced in iPS-neurons by exposure to material from Alzheimer’s brains. You will develop an iPS-neuronal-microglial co-culture screening platform that can assess